Product Information
ASPIRIN-DIPYRIDAM ER 25-200 MG is a generic product labeled by NorthStar Rx LLC, priced at $0.5592 per EA under NDC 16714096401. Its NADAC has been published 359 times since Oct 9, 2019.
FDA first approved this application on Oct 10, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 200 mg/1; mg/1
Manufacturer
NorthStar Rx LLCNDC
16714096401
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ASPIRIN; DIPYRIDAMOLEApproval Type
Generic (ANDA)
FDA Application
ANDA209048FDA Approved
10/10/2018
TE Code
AB
On Market Since
4/3/2019
Pharmacological Classes
Price Statistics
The NADAC for ASPIRIN-DIPYRIDAM ER 25-200 MG has been published 359 times since Oct 9, 2019, and over the history we have for it it has declined 84.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5592 per EA |
|---|---|
| All-time high | $3.5475 (Oct 16, 2019) |
| All-time low | $0.5561 (Mar 18, 2026) |
| 52-week high | $0.6072 |
| 52-week low | $0.5561 |
| Median price | $0.7763 |
| Average price | $0.9897 |
| Largest weekly change | +44.2% (Apr 21, 2021) |
| Weeks tracked | 359 |
| Tracking since | Oct 9, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ASPIRIN-DIPYRIDAM ER 25-200 MG?
The current National Average Drug Acquisition Cost (NADAC) for ASPIRIN-DIPYRIDAM ER 25-200 MG, manufactured by NorthStar Rx LLC, is $0.5592 per EA (NDC 16714096401), effective Aug 19, 2026.
How has the price of ASPIRIN-DIPYRIDAM ER 25-200 MG changed over time?
Over the history we have for it, the NADAC for ASPIRIN-DIPYRIDAM ER 25-200 MG has declined 84.2%. It has been tracked across 359 weekly CMS publications since Oct 9, 2019.
What are the highest and lowest recorded NADAC prices for ASPIRIN-DIPYRIDAM ER 25-200 MG?
Since Oct 9, 2019, the NADAC for ASPIRIN-DIPYRIDAM ER 25-200 MG has ranged from a low of $0.5561 (Mar 18, 2026) to a high of $3.5475 (Oct 16, 2019), with a median of $0.7763 per EA.
Are there cheaper alternatives to ASPIRIN-DIPYRIDAM ER 25-200 MG?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ASPIRIN-DIPYRIDAM ER 25-200 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures ASPIRIN-DIPYRIDAM ER 25-200 MG?
ASPIRIN-DIPYRIDAM ER 25-200 MG (NDC 16714096401) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.